Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement

Background: Outcomes-based agreements (OBA) are performance-based risk-sharing agreements between manufacturers and payers which provide the opportunity for collection and evaluation of real-world outcomes to supplement clinical trials. Objectives: To describe an OBA comparing ticagrelor to clopidog...

Full description

Bibliographic Details
Main Authors: Samuel K. Peasah, Yan Huang, John Venditto, Robert Brekosky, Daniel Belletti, Vanessa Campbell, Chronis Manolis, Chester B. Good
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Exploratory Research in Clinical and Social Pharmacy
Subjects:
Ticagrelor
Clopidogrel
Myocardial infarction
Acute coronary syndrome
Outcomes research
Online Access:http://www.sciencedirect.com/science/article/pii/S2667276623001282

Internet

http://www.sciencedirect.com/science/article/pii/S2667276623001282

Similar Items